Analysis Metabolite Name Measured Value Units CASE_CONTROL Chemotherapy Drug Race TIMEPOINT Tamoxyfen Taxane
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-552025Peak areaControl N Letrozole White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-607864Peak areaControl N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-751179Peak areaCase N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-821837Peak areaControl Y Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-831619Peak areaCase Y Exemestane White Baseline N Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-839874Peak areaCase N Letrozole White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-869786Peak areaCase Y Exemestane White Baseline Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-875901Peak areaCase Y Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-876221Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-878133Peak areaControl N Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-883025Peak areaControl N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-887825Peak areaControl Y Exemestane White 3 Month N Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-895100Peak areaCase N Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-900931Peak areaControl N Letrozole White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-909539Peak areaCase N Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-922713Peak areaCase N Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-937861Peak areaControl Y Exemestane White Baseline N Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-955406Peak areaCase N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-961058Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-966731Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-981654Peak areaControl N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-982308Peak areaCase N Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-982474Peak areaCase N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1015321Peak areaCase N Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1018054Peak areaControl Y Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1019085Peak areaCase N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1031748Peak areaCase Y Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1033725Peak areaControl Y Exemestane White Baseline N Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1042050Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1043205Peak areaControl N Letrozole White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1053326Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1056644Peak areaControl N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1060738Peak areaCase N Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1061735Peak areaCase Y Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1064044Peak areaControl N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1066397Peak areaCase Y Exemestane White Baseline Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1078029Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1082601Peak areaControl Y Letrozole White Baseline Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1091681Peak areaControl Y Exemestane White 3 Month N Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1092693Peak areaControl N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1094471Peak areaControl Y Letrozole White Baseline Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1104440Peak areaControl Y Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1115157Peak areaCase N Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1117091Peak areaCase N Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1117671Peak areaControl N Letrozole Black 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1118724Peak areaCase N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1119376Peak areaControl Y Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1119446Peak areaCase N Letrozole Black Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1135736Peak areaControl Y Letrozole White 3 Month Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1142568Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1151272Peak areaCase Y Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1152087Peak areaCase Y Exemestane White 3 Month Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1152466Peak areaCase N Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1154664Peak areaControl N Letrozole White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1157102Peak areaControl Y Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1159398Peak areaControl Y Letrozole White 3 Month Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1175577Peak areaControl N Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1179153Peak areaCase N Exemestane Black Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1193332Peak areaCase N Exemestane Black 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1202999Peak areaControl N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1216301Peak areaControl N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1219303Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1236517Peak areaCase Y Exemestane Black Baseline N Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1237128Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1241684Peak areaControl N Exemestane Black Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1243530Peak areaControl Y Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1244308Peak areaCase N Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1245121Peak areaCase N Letrozole Black 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1251289Peak areaControl N Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1261087Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1282306Peak areaControl N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1285278Peak areaControl N Letrozole Black Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1289706Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1292083Peak areaControl N Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1292511Peak areaControl N Letrozole White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1294109Peak areaControl N Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1300334Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1301561Peak areaCase N Letrozole White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1331478Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1337782Peak areaControl N Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1355504Peak areaControl Y Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1360528Peak areaControl N Exemestane Black 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1368732Peak areaControl Y Exemestane White 3 Month Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1396205Peak areaControl N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1396635Peak areaControl Y Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1411894Peak areaCase Y Exemestane Black 3 Month N Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1412419Peak areaCase Y Exemestane White Baseline N Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1415058Peak areaCase N Letrozole White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1426999Peak areaControl Y Exemestane White Baseline Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1428373Peak areaControl N Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1438866Peak areaCase N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1447749Peak areaCase N Letrozole White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1475803Peak areaCase Y Exemestane White 3 Month Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1483179Peak areaControl Y Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1517231Peak areaControl N Letrozole White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1517937Peak areaControl N Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1599818Peak areaCase N Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1634561Peak areaCase Y Exemestane White Baseline N Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1643407Peak areaCase N Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M+CL)-1645239Peak areaCase Y Exemestane White Baseline N Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-874716Peak areaControl N Letrozole White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-954319Peak areaControl N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1191465Peak areaCase N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1237316Peak areaCase Y Exemestane White Baseline N Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1272214Peak areaCase Y Exemestane White Baseline Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1272381Peak areaControl Y Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1281106Peak areaControl N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1339434Peak areaControl N Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1342150Peak areaControl Y Exemestane White 3 Month N Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1352000Peak areaCase N Letrozole White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1357052Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1379723Peak areaCase N Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1380461Peak areaCase Y Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1382733Peak areaCase N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1386351Peak areaCase N Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1423475Peak areaControl N Letrozole White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1433536Peak areaCase N Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1436082Peak areaControl N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1455513Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1499117Peak areaCase N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1499984Peak areaCase N Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1510902Peak areaCase Y Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1529589Peak areaCase N Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1531187Peak areaControl Y Exemestane White Baseline N Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1531463Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1538014Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1544050Peak areaCase N Letrozole White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1551044Peak areaCase N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1582166Peak areaControl N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1594752Peak areaControl Y Exemestane White 3 Month N Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1613682Peak areaCase N Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1618358Peak areaControl Y Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1619801Peak areaControl N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1625253Peak areaCase Y Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1625621Peak areaControl N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1626416Peak areaControl Y Exemestane White Baseline N Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1633189Peak areaControl Y Letrozole White Baseline Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1636692Peak areaCase N Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1644803Peak areaControl Y Letrozole White Baseline Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1645516Peak areaCase N Letrozole Black Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1652666Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1656939Peak areaControl N Letrozole White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1661526Peak areaCase N Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1665924Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1674104Peak areaControl Y Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1686416Peak areaCase Y Exemestane White Baseline Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1699631Peak areaCase N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1714270Peak areaControl N Letrozole Black 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1716903Peak areaControl Y Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1717911Peak areaCase Y Exemestane White 3 Month Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1723398Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1744122Peak areaCase N Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1763369Peak areaCase N Letrozole Black 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1767138Peak areaControl Y Letrozole White 3 Month Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1769433Peak areaControl N Letrozole White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1777275Peak areaControl N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1793117Peak areaCase Y Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1808493Peak areaControl Y Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1839274Peak areaControl N Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1842503Peak areaControl Y Letrozole White 3 Month Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1843586Peak areaControl N Exemestane Black Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1858238Peak areaControl Y Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1864113Peak areaCase N Letrozole White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1865670Peak areaControl N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1870438Peak areaControl N Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1877878Peak areaControl Y Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1882801Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1884796Peak areaCase Y Exemestane Black Baseline N Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1898751Peak areaCase N Exemestane Black 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1903330Peak areaControl N Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1918710Peak areaCase N Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1950392Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1962863Peak areaControl N Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1979716Peak areaCase N Exemestane Black Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1985048Peak areaControl N Letrozole White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-1986221Peak areaControl N Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2025013Peak areaControl N Exemestane Black 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2032061Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2034151Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2049359Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2060141Peak areaControl N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2061792Peak areaControl N Letrozole Black Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2086737Peak areaCase Y Exemestane White Baseline N Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2100439Peak areaControl Y Exemestane White 3 Month Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2131992Peak areaControl N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2178332Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2191503Peak areaCase Y Exemestane Black 3 Month N Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2238284Peak areaControl N Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2244717Peak areaCase N Letrozole White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2246055Peak areaControl Y Exemestane White Baseline Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2253769Peak areaCase Y Exemestane White 3 Month Y Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2258892Peak areaControl Y Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2321616Peak areaCase N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2332716Peak areaControl Y Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2417796Peak areaCase N Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2454807Peak areaControl N Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2521496Peak areaControl N Letrozole White Baseline N N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2566614Peak areaCase N Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2574660Peak areaCase Y Exemestane White Baseline N Y
Reversed phase NEGATIVE ION MODEZEATIN [ISTD] (CAS# 13114-27-7); (M-H)-2621243Peak areaCase Y Exemestane White Baseline N Y

Return to search page
  logo